Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19.

Saved in:
Bibliographic Details
Title: Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19.
Authors: Xie X; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA. xuxie@UTMB.edu., Muruato AE; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Zhang X; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA., Lokugamage KG; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Fontes-Garfias CR; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA., Zou J; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA., Liu J; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Ren P; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA., Balakrishnan M; Gilead Sciences, Inc., Foster City, CA, USA., Cihlar T; Gilead Sciences, Inc., Foster City, CA, USA., Tseng CK; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Makino S; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Menachery VD; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA., Bilello JP; Gilead Sciences, Inc., Foster City, CA, USA. john.bilello@gilead.com., Shi PY; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.; Sealy Center for Structural Biology & Molecular Biophysics, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.
Source: Nature communications [Nat Commun] 2021 Jun 21; Vol. 12 (1), pp. 3984. Date of Electronic Publication: 2021 Jun 21.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2041-1723
DOI:10.1038/s41467-021-24300-8